Fiber Formula Study Among Radiation Oncology Patients
Pilot Study: "Does Using a Fiber Containing Enteral Tube Feeding Formula Increase Constipation and the Use of Stool Softeners in Patients Undergoing Radiation Therapy and Have a Percutaneous Endoscopic Gastrostomy (PEG) Placed?"
1 other identifier
observational
19
1 country
1
Brief Summary
During radiation treatment for head and neck cancer a large percentage of patients at Mayo Clinic Rochester develop the need for tube feeding to meet nutrition and hydration needs. These patients are usually taking pain medication along with a stool softener or laxative. Currently, when these patients get a feeding tube it is our standard practice to choose a fiber-free enteral tube feeding formula as to not worsen their constipation. Currently, there are no guidelines as to which patients are good candidates for fiber containing enteral tube feeding formulas. The investigators hope this study will help determine if fiber containing enteral tube feeding formulas can be used for patients undergoing radiation for head and neck cancer without increasing rates of constipation or increasing use of stool softeners/laxatives. Hypothesis: Participants enrolled in the study will not have increased rates of constipation on fiber-containing enteral tube feeding formula compared to historical standards on fiber-free formula.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2009
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2009
CompletedFirst Submitted
Initial submission to the registry
April 24, 2009
CompletedFirst Posted
Study publicly available on registry
April 27, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedSeptember 26, 2011
September 1, 2011
2.2 years
April 24, 2009
September 23, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Whether each patient gets constipated.
Weekly for 2 weeks
Secondary Outcomes (1)
Whether the amount of stool softeners/laxatives increases in comparison to the original recommended regimen, for each individual patient.
Weekly for 2 weeks
Study Arms (1)
Fiber formula
This group will receive tube feeding formula that contains fiber.
Interventions
This group will be prescribed adequate calories, protein and fluid using a formula that contains fiber.
Eligibility Criteria
These participants have head and neck cancer, are undergoing radiaiton therapy and will have a percutaneous endoscopic gastrostomy (PEG) placed.
You may qualify if:
- Cancer of: 1) lip/oral cavity 2) pharynx 3) larynx 4) nasal cavity/paranasal sinus 5) salivary gland 6) Thyroid according to AJCC cancer staging manual 6th edition 2002
- Current radiation therapy or starting radiation therapy in the next 2 weeks
- Patient must have a gastrostomy tube
You may not qualify if:
- Jejunostomy tube
- Diagnosis of Irritable Bowel Syndrome (abdominal pain and diarrhea or constipation lasting at least three months in one year)
- Short bowel (A patient is generally considered to have short bowel syndrome when less than 100 to 150 centimeters of functioning small bowel remains)
- Body max index (BMI) \<18.5kg/m2
- Gastroparesis (when the stomach retains food for longer than normal periods). This must be diagnosed with a gastric emptying study.
- Use of Metoclopramide
- Receiving 5-FU chemotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa M Epp, BS
Mayo Clinic
- STUDY DIRECTOR
Yolanda I Garces, MD
Mayo Clinic
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Home Enteral Nutrition Coordinator
Study Record Dates
First Submitted
April 24, 2009
First Posted
April 27, 2009
Study Start
April 1, 2009
Primary Completion
July 1, 2011
Study Completion
July 1, 2011
Last Updated
September 26, 2011
Record last verified: 2011-09